FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

Boehringer Ingelheim Pharmaceuticals Mobic Recall

Mobic (meloxicam) tablets, 15 mg, package in 100-count bottle, Rx only, Dist

Boehringer Ingelheim Pharmaceuticals, Inc. · Danbury, CT

Risk level
Class III
Reported by FDA
Oct 18, 2017
Recall ID
D-0007-2018
Check your lot numberHow we source this data

Summary

Boehringer Ingelheim Pharmaceuticals recalled Mobic starting Sep 22, 2017. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-0007-2018 on Oct 18, 2017. Reason: Labeling: Incorrect or missing package insert. One lot of Mobic Tablets is packaged with an incorrect insert. Status: Terminated.

Why it was recalled

Labeling: Incorrect or missing package insert. One lot of Mobic Tablets is packaged with an incorrect insert.

Product description

Mobic (meloxicam) tablets, 15 mg, package in 100-count bottle, Rx only, Dist. by: Boehringer Ingelheim (BI) Pharmaceuticals, Inc., Ridgefield, CT 06877 USA, Lic. from: BI Int'l GmbH, Made in Italy, NDC 0597-0030-01

Lot numbers, UPCs & expiration codes

Lot 754037

Where it was sold

CO, OH

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0007-2018
Classification
Class III
Status
Terminated
Recall initiated
Sep 22, 2017
FDA report date
Oct 18, 2017
Quantity
128 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Boehringer Ingelheim Pharmaceuticals, Inc.

Original FDA data

Every field from FDA enforcement report D-0007-2018, exactly as published.

Show all FDA fields
City
Danbury
State
CT
Status
Terminated
Country
United States
Event ID
78172
Address
39 Briar Ridge Rd.
Code information
Lot 754037
Postal code
06810
Report date
Oct 18, 2017
Product type
Drugs
Recall number
D-0007-2018
Classification
Class III
Recalling firm
Boehringer Ingelheim Pharmaceuticals, Inc.
Product quantity
128 bottles
Termination date
Apr 18, 2018
Reason for recall
Labeling: Incorrect or missing package insert. One lot of Mobic Tablets is packaged with an incorrect insert.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Mobic (meloxicam) tablets, 15 mg, package in 100-count bottle, Rx only, Dist. by: Boehringer Ingelheim (BI) Pharmaceuticals, Inc., Ridgefield, CT 06877 USA, Lic. from: BI Int'l GmbH, Made in Italy, NDC 0597-0030-01
Distribution pattern
CO, OH
Recall initiation date
Sep 22, 2017
Initial firm notification
Letter
Center classification date
Oct 6, 2017

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0007-2018, published Oct 18, 2017. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls